MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1

被引:0
作者
Lin Lu
Fang Ju
Hui Zhao
Xuezhen Ma
机构
[1] The Second Affiliated Hospital of Qingdao Medical College,Department of Oncology
来源
Biotechnology Letters | 2015年 / 37卷
关键词
ABCC1; Breast cancer; Doxorubicin; Doxorubicin resistance; Drug resistance; MicroRNA-134; MRP1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2387 / 2394
页数:7
相关论文
共 180 条
[1]  
Alder H(2012)Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer Carcinogenesis 33 1736-1744
[2]  
Taccioli C(2003)Metastatic breast cancer: overview of treatment Clin Orthopaed Rel Res 415 S132-S137
[3]  
Chen H(2007)Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells Anticancer Res 27 351-355
[4]  
Jiang Y(2004)MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 281-297
[5]  
Smalley KJ(2009)MicroRNAs: novel biomarkers for human cancer Clin Chem 55 623-631
[6]  
Fadda P(2006)Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1 Leukemia 20 95-102
[7]  
Ozer HG(1992)Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1650-1654
[8]  
Huebner K(2006)Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins Physiol Rev 86 849-899
[9]  
Farber JL(2014)Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors Breast Cancer Res 16 R55-251
[10]  
Croce CM(2012)Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: where are we now and where are we going? Crit Rev Oncol/Hematol 84 243-95